Venus Medtech (Hangzhou), Inc. Class H(HK:2500)
HK$0.99-0.01 (-1.00%)
HK:2500
Venus Medtech (Hangzhou), Inc. Class H financials statements
HK$0.99
At close:-0.01 (-1.00%)
Want to see HK:2500 full AI Analyst Report?
Venus Medtech (Hangzhou), Inc. Class H (2500) Income Statement
1 Followers
Venus Medtech (Hangzhou), Inc. Class H Income Statement
Last quarter (Q2 2026), Venus Medtech (Hangzhou), Inc. Class H's total revenue was ¥135.65M, a decrease of 41.21% from the same quarter last year. In Q2, Venus Medtech (Hangzhou), Inc. Class H's net income was ¥-191.52M. See Venus Medtech (Hangzhou), Inc. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 306.79M | ¥ 470.83M | ¥ 491.37M | ¥ 406.46M | ¥ 415.86M | |
| ¥ 211.83M | ¥ 367.75M | ¥ 389.20M | ¥ 314.00M | ¥ 324.34M | |
| ¥ 557.15M | ¥ 714.34M | ¥ 977.75M | ¥ 948.88M | ¥ 596.30M | |
| Depreciation and Amortization | ¥ 97.33M | ¥ 111.11M | ¥ 124.79M | ¥ 112.35M | ¥ 51.62M |
| ¥ -247.99M | ¥ -612.96M | ¥ -547.84M | ¥ -999.37M | ¥ -324.03M | |
| ¥ -345.32M | ¥ -346.60M | ¥ -589.97M | ¥ -650.21M | ¥ -278.64M | |
| ¥ -59.57M | ¥ -394.12M | ¥ -146.79M | ¥ -506.13M | ¥ -98.91M | |
| ¥ -404.89M | ¥ -740.71M | ¥ -735.34M | ¥ -1.16B | ¥ -377.56M | |
| ¥ -407.69M | ¥ -714.31M | ¥ -703.75M | ¥ -1.06B | ¥ -373.64M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.93 | ¥ -1.77 | ¥ -1.61 | ¥ -2.42 | ¥ -0.85 |
| Diluted EPS | ¥ -0.93 | ¥ -1.77 | ¥ -1.61 | ¥ -2.42 | ¥ -0.85 |
| Weighted Average Shares Outstanding | 437.90M | 437.90M | 437.90M | 437.90M | 438.58M |
| Weighted Average Shares Outstanding (Diluted) | 437.90M | 437.90M | 437.90M | 437.90M | 438.58M |
Currency in CNY

